# To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines

> **NCT00140686** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3994 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **BIOLOGICAL:** Rotavirus (vaccine)

## Key facts

- **NCT ID:** NCT00140686
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 3994 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140686, "To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00140686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*